Skip to content

Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence and Outcomes

Development of a Targeted Patient Portal Intervention to Improve Depression Treatment Adherence, Satisfaction, and Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04646681
Acronym
Patient Portal
Enrollment
30
Registered
2020-11-30
Start date
2021-03-31
Completion date
2022-04-30
Last updated
2022-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

patient portals, treatment adherence

Brief summary

The purpose of this research study is to learn how best to use patient portals to help improve the treatment of mood disorders.

Detailed description

This study is being done in 3 phases. First 2 phases were observational with total enrollment of 300 subjects. The final 3rd phase is interventional and we are anticipating to enroll 50 subjects. It is described below. Patients being treated for depressive symptoms at the University of Iowa, Department of Psychiatry are invited to participate. Participants will complete a remote (phone or video) visit. After being informed about the study and potential risks, those who consent to being in the study will be assigned to one of two groups. They will complete an online survey and receive some basic training on patient portals. After the visit. both groups will be followed for 6 months. Depending on their group assignment, they will complete: * two to five phone calls with a study team member and * two to five online questionnaires

Interventions

BEHAVIORALConnectCare

increased monitoring between clinical mental health visits

Sponsors

Carolyn L Turvey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* English speaking, * PHQ-9 score of 10 or higher (questions 1-8 only), * Taking medication for depressive symptoms, * 1 or more appointments scheduled or planned with University of Iowa psychiatry provider in next 6 months, * Home computer w/internet access, * MyChart (University of Iowa Healthcare's patient portal) account/MyChart enrollment

Exclusion criteria

* Psychotic disorder/symptoms, * Current substance use disorders (other than alcohol, tobacco, marijuana), * Active suicidal ideation within past 1 year, * Cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-9)Once per month for 6 monthsmeasures the severity of depression symptoms

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026